Dr. Childs grew up in Abilene, Texas, and went to college at Tulane University and medical school at L.S.U., both in New Orleans. He did his internship and residencies in Birmingham, Alabama, and practiced urology there for seventeen years. He and his wife moved to Cheyenne, Wyoming in 1995, where he practiced urology for nine years. His love of the mountains and skiing brought him to Steamboat Springs in May of 2004.
Dr. Childs was active in clinical research for twenty-eight years and started three research companies, one of which went public. His early interests in infection and inflammation of the urinary tract led him to the faculty of The University of Colorado in Denver where he was appointed Clinical Professor of Surgery in the division of Urology in 1999—a position which he currently holds.
He has been on various committees including chairman of the Medical School Admissions Committee for Wyoming and the Wyoming Governor’s Healthcare Commission and was a delegate to the American Medical Association. Dr. Childs is certified by The American Board of Urology and is a Fellow of the American College of Surgeons. He is a consulting editor to the journal Urology, and is former editor-in-chief of Issues in Urology and the urology section of Medscape, among others. He has authored three medical texts, six chapters in medical books, and published over seventy-five articles in peer-reviewed medical journals. Dr. Childs began writing fiction in 2006.
Dr. Childs was the first medical Director of Cancer Services for YVMC Yampa Valley Medical Center. He has been listed in Americas Top Doctors since the fifth edition of the organization and has been listed in Best Doctors in America every year since 2007.
In addition to practicing urology for nearly four decades, Dr. Childs enjoys ski racing, road biking, hiking, fly fishing, and rifle and hand gun target shooting. He was a torch carrier for the Salt Lake City Olympics, after which he ran two marathons in four weeks, the last one in New York. He is a prostate cancer survivor.